Table 1 Characteristics of the study and control groups
Study group (n = 18) | Control group (n = 33) | Test result | ||
|---|---|---|---|---|
Sex | Women | 10 (55.6) | 22 (66.7) | χ2 = 0.62; p = 0.433 |
Men | 8 (44.4) | 11 (33.3) | ||
Age | Range | 40–85 | 29–78 | U = 234.5; p = 0.218 |
M (SD) | 60.5 (12.4) | 55.3 (13.5) | ||
Duration of paralysis (years) | Range | 0.5–23 | 0.5–33 | U = 231.5; p = 0.191 |
M (SD) | 4.3 (6.3) | 3.9 (5.8) | ||
Paralysed VF | Right | 7 (38.9) | 13 (39.4) | χ2 = 0.01; p = 0.972 |
Left | 11 (61.1) | 20 (60.6) | ||
Augmented VF | Right | 4 (22.2) | 11 (33.3) | χ2 = 0.71; p = 0.702 |
Left | 8 (44.4) | 13 (39.4) | ||
Both | 6 (33.4) | 9 (27.3) | ||
Injected material (to a paralysed VF) | CaHA | 7 (38.9) | 8 (24.2) | χ2 = 1.23; p = 0.541 |
HA | 9 (50.0) | 21 (63.6) | ||
CaHA & HA | 2 (11.1) | 4 (12.1) | ||
Amount of injected material (in all) | Range | 0.4–1.8 | 0.94 (0.36) | U = 2 50.5; p = 0.897 |
M (SD) | 0.4–2.1 | 0.97 (0.41) | ||
Rehabilitation before augmentation | Yes | 14 (77.8) | 24 (72.7) | χ2 = 0.16; p = 0.692 |
No | 4 (22.2) | 9 (27.3) | ||
Rehabilitation after augmentation | Yes | 9 (50.0) | 19 (57.6) | χ2 = 0.27; p = 0.603 |
No | 9 (50.0) | 14 (42.4) |